Follow the Sionna Therapeutics, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2bn. The latest transaction was disclosed on 9 July 2026 (Cession). Among the most active insiders: Booth Bruce. The full history is openly available.
52
Insider Decl.
n/a
Thresholds
€812,849
1 ops.
Buy Volume
€58m
36 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sionna Therapeutics, Inc. Buy (bullish), based on 10 analysts. Average price target: US$51.60.
57Σ signal
Buys €812,849€58m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
5,316 shares@ US$35.694.2% of flowCommon StockSEC:0001451612-25-000012:7
25 of 52 declarations
About Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. is a company focused on developing innovative therapies for the treatment of neurological diseases. It is listed on the XNAS market.